細胞分析用イメージベースサイトメトリーの世界市場（2023年-2031年）：バイオテクノロジー・製薬会社、学術、化粧品産業、受託研究機関、受託開発・製造機関

• 英文タイトル：Image Based Cytometry in Cell Analysis Market (End-user: Biotechnology & Pharmaceutical Companies, Academia, Cosmetic Industry, Contract Research Organizations, and Contract Development & Manufacturing Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Image Based Cytometry in Cell Analysis Market (End-user: Biotechnology & Pharmaceutical Companies, Academia, Cosmetic Industry, Contract Research Organizations, and Contract Development & Manufacturing Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031「細胞分析用イメージベースサイトメトリーの世界市場（2023年-2031年）：バイオテクノロジー・製薬会社、学術、化粧品産業、受託研究機関、受託開発・製造機関」（市場規模、市場予測）調査レポートです。• レポートコード：MRC2312A035
• 出版社/出版日：Transparency Market Research / 2023年8月23日
• レポート形態：英文、PDF、179ページ
• 納品方法：Eメール
• 産業分類：バイオ
• 販売価格（消費税別）
  Single User￥834,480 (USD5,795)▷ お問い合わせ
  Multi User￥1,266,480 (USD8,795)▷ お問い合わせ
  Corporate License￥1,698,480 (USD11,795)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
細胞分析用イメージベースサイトメトリー市場 - レポートの範囲
TMRの調査レポート「世界の細胞分析用イメージベースサイトメトリー市場」は、2023年から2031年までの予測期間における市場の指標に関する貴重な洞察を得るために、過去だけでなく現在の成長動向と機会を調査しています。2023年を基準年、2031年を予測年として、2017年から2031年までの世界の細胞分析用イメージベースサイトメトリー市場の収益を提供しています。また、2023年から2031年までの世界の細胞分析用イメージベースサイトメトリー市場の複合年間成長率（CAGR %）も掲載しています。

本レポートは広範な調査を経て作成されました。主要オピニオンリーダー、業界リーダー、オピニオンメーカーへのインタビューを実施しました。二次調査では、主要企業の製品資料、年次報告書、プレスリリース、関連文書などを参照し、細胞分析用イメージベースサイトメトリー市場を理解しました。

二次調査には、インターネットソース、政府機関の統計データ、ウェブサイト、業界団体なども含まれます。アナリストはトップダウンアプローチとボトムアップアプローチを組み合わせて、世界の細胞分析用イメージベースサイトメトリー市場の様々な属性を調査しました。

本レポートには、調査範囲に含まれる様々なセグメントの成長動向のスナップショットとともに、詳細なエグゼクティブサマリーが含まれています。さらに、本レポートは世界の細胞分析用イメージベースサイトメトリー市場における競争ダイナミクスの変化に光を投げかけています。これらは、既存の市場プレイヤーだけでなく、世界の細胞分析用イメージベースサイトメトリー市場への参入に関心のある企業にとっても貴重なツールとなります。

本レポートでは、世界の細胞分析用イメージベースサイトメトリー市場の競争状況について掘り下げています。世界の細胞分析用イメージベースサイトメトリー市場で事業を展開する主要プレイヤーを特定し、各プレイヤーを様々な属性でプロファイルしています。会社概要、財務状況、最近の動向、SWOTは、本レポートで紹介されている世界の細胞分析用イメージベースサイトメトリー市場におけるプレイヤーの属性です。

世界の細胞分析用イメージベースサイトメトリー市場レポートで回答された主な質問
- 予測期間中の全地域における細胞分析用イメージベースサイトメトリーの売上高/収益は？
- 世界の細胞分析用イメージベースサイトメトリー市場におけるビジネスチャンスは？
- 市場の主な促進要因、阻害要因、機会、脅威は？
- 予測期間中に最も速いCAGRで拡大する地域市場は？
- 2031年に世界で最も高い収益を上げると予測されるセグメントは？
- 予測期間中に最も高いCAGRで拡大すると予測されるセグメントは？
- 世界市場で事業を展開する各企業の市場ポジションは？

細胞分析用イメージベースサイトメトリー市場 - 調査目的と調査アプローチ
世界の細胞分析用イメージベースサイトメトリー市場に関する包括的なレポートは、概要から始まり、調査範囲と目的が続きます。本レポートでは、本調査の目的、市場で事業を展開する主要ベンダーと流通業者、製品の承認に関する規制シナリオについて詳しく解説しています。

本レポートは、読みやすさを考慮し、各セクションを章ごとに分割したレイアウトになっています。本レポートは、グラフと表を適切に配置した網羅的なコレクションで構成されています。主要セグメントの実績値と予測値を図式化することで、読者に視覚的に訴えかけます。また、主要セグメントの過去と予測期間末の市場シェアの比較も可能です。

本レポートでは、世界の細胞分析用イメージベースサイトメトリー市場を製品、エンドユーザー、地域の観点から分析。各基準の主要セグメントを詳細に調査し、2031年末時点の各セグメントにおける市場シェアを掲載しています。このような貴重な洞察により、市場関係者は世界細胞分析用イメージベースサイトメトリー市場への投資について十分な情報に基づいたビジネス上の意思決定を行うことができます。

1.　序論
2.　仮定・調査方法
3.　市場概要
4.　世界の細胞分析用イメージベースサイトメトリー市場分析・予測：エンドユーザー別
5.　世界の細胞分析用イメージベースサイトメトリー市場分析・予測：治療領域別
6.　世界の細胞分析用イメージベースサイトメトリー市場分析・予測：作業場所別
7.　世界の細胞分析用イメージベースサイトメトリー市場分析・予測：国/地域別
8.　アメリカの細胞分析用イメージベースサイトメトリー市場分析・予測
9.　ヨーロッパの細胞分析用イメージベースサイトメトリー市場分析・予測
10.　中国の細胞分析用イメージベースサイトメトリー市場分析・予測
11.　その他地域の細胞分析用イメージベースサイトメトリー市場分析・予測
12.　競争状況

レポート目次

1. Preface
    1.1. Market Definition and Scope
    1.2. Key Research Objectives
2. Assumptions and Research Methodology
3. Market Overview
    3.1. Overview
    3.2. Market Dynamics
        3.2.1. Drivers
        3.2.2. Restraints
        3.2.3. Opportunities
4. Global Image-based Cytometry in Cell Analysis Market Analysis and Forecast, by End-user
    4.1. Introduction & Definition
    4.2. Key Findings/Developments
    4.3. Market Value Forecast, by End-user, 2017-2031
        4.3.1. Biotechnology & Pharmaceutical Companies
        4.3.2. Academia
        4.3.3. Cosmetic Industry
        4.3.4. Contract Research Organizations
        4.3.5. Contract Development & Manufacturing Organizations
5. Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Analysis and Forecast, by Therapeutic Area
    5.1. Introduction & Definition
    5.2. Key Findings/Developments
    5.3. Market Value Forecast, by Therapeutic Area, 2015-2031
        5.3.1. Oncology & Immune-oncology
            5.3.1.1. Small Molecules
            5.3.1.2. Protein-based Therapeutics
            5.3.1.3. Cell Therapy
            5.3.1.4. Nucleic Acid-based Drugs
        5.3.2. Cardiovascular & Metabolic Diseases
            5.3.2.1. Small Molecules
            5.3.2.2. Protein-based Therapeutics
            5.3.2.3. Cell Therapy
            5.3.2.4. Nucleic Acid-based Drugs
        5.3.3. Immunology
            5.3.3.1. Small Molecules
            5.3.3.2. Protein-based Therapeutics
            5.3.3.3. Cell Therapy
            5.3.3.4. Nucleic Acid-based Drugs
        5.3.4. Rare Diseases
            5.3.4.1. Small Molecules
            5.3.4.2. Protein-based Therapeutics
            5.3.4.3. Cell Therapy
            5.3.4.4. Nucleic Acid-based Drugs
        5.3.5. Neurological Diseases
            5.3.5.1. Small Molecules
            5.3.5.2. Protein-based Therapeutics
            5.3.5.3. Cell Therapy
            5.3.5.4. Nucleic Acid-based Drugs
        5.3.6. Others
            5.3.6.1. Small Molecules
            5.3.6.2. Protein-based Therapeutics
            5.3.6.3. Cell Therapy
            5.3.6.4. Nucleic Acid-based Drugs
6. Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Analysis and Forecast, by Workplace
    6.1. Introduction & Definition
    6.2. Key Findings/Developments
    6.3. Market Value Forecast, by Workplace, 2016-2031
        6.3.1. Target Identification
        6.3.2. Hit Generation & Lead Identification
        6.3.3. Lead Optimization
        6.3.4. In Vitro Preclinical Studies
        6.3.5. In Vivo Preclinical Studies
        6.3.6. Clinical Studies
7. Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Analysis and Forecast, by Country/Region
    7.1. Key Findings
    7.2. Market Value Forecast, by Country/Region, 2017-2031
        7.2.1. U.S.
        7.2.2. Europe
        7.2.3. China
        7.2.4. Rest of the World
8. U.S. Image-based Cytometry in Cell Analysis Market Analysis and Forecast
    8.1. Introduction
        8.1.1. Key Findings
    8.2. Market Value Forecast, by End-user, 2017-2031
        8.2.1. Biotechnology & Pharmaceutical Companies
        8.2.2. Academia
        8.2.3. Cosmetic Industry
        8.2.4. Contract Research Organizations
        8.2.5. Contract Development & Manufacturing Organizations
    8.3. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Therapeutic Area, 2017-2031
        8.3.1. Oncology & Immune-oncology
            8.3.1.1. Small Molecules
            8.3.1.2. Protein-based Therapeutics
            8.3.1.3. Cell Therapy
            8.3.1.4. Nucleic Acid-based Drugs
        8.3.2. Cardiovascular & Metabolic Diseases
            8.3.2.1. Small Molecules
            8.3.2.2. Protein-based Therapeutics
            8.3.2.3. Cell Therapy
            8.3.2.4. Nucleic Acid-based Drugs
        8.3.3. Immunology
            8.3.3.1. Small Molecules
            8.3.3.2. Protein-based Therapeutics
            8.3.3.3. Cell Therapy
            8.3.3.4. Nucleic Acid-based Drugs
        8.3.4. Rare Diseases
            8.3.4.1. Small Molecules
            8.3.4.2. Protein-based Therapeutics
            8.3.4.3. Cell Therapy
            8.3.4.4. Nucleic Acid-based Drugs
        8.3.5. Neurological Diseases
            8.3.5.1. Small Molecules
            8.3.5.2. Protein-based Therapeutics
            8.3.5.3. Cell Therapy
            8.3.5.4. Nucleic Acid-based Drugs
        8.3.6. Others
            8.3.6.1. Small Molecules
            8.3.6.2. Protein-based Therapeutics
            8.3.6.3. Cell Therapy
            8.3.6.4. Nucleic Acid-based Drugs
    8.4. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Workplace, 2017-2031
        8.4.1. Target Identification
        8.4.2. Hit Generation & Lead Identification
        8.4.3. Lead Optimization
        8.4.4. In Vitro Preclinical Studies
        8.4.5. In Vivo Preclinical Studies
        8.4.6. Clinical Studies
9. Europe Image-based Cytometry in Cell Analysis Market Analysis and Forecast
    9.1. Introduction
        9.1.1. Key Findings
    9.2. Market Value Forecast, by End-user, 2017-2031
        9.2.1. Biotechnology & Pharmaceutical Companies
        9.2.2. Academia
        9.2.3. Cosmetic Industry
        9.2.4. Contract Research Organizations
        9.2.5. Contract Development & Manufacturing Organizations
    9.3. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Therapeutic Area, 2017-2031
        9.3.1. Oncology & Immune-oncology
            9.3.1.1. Small Molecules
            9.3.1.2. Protein-based Therapeutics
            9.3.1.3. Cell Therapy
            9.3.1.4. Nucleic Acid-based Drugs
        9.3.2. Cardiovascular & Metabolic Diseases
            9.3.2.1. Small Molecules
            9.3.2.2. Protein-based Therapeutics
            9.3.2.3. Cell Therapy
            9.3.2.4. Nucleic Acid-based Drugs
        9.3.3. Immunology
            9.3.3.1. Small Molecules
            9.3.3.2. Protein-based Therapeutics
            9.3.3.3. Cell Therapy
            9.3.3.4. Nucleic Acid-based Drugs
        9.3.4. Rare Diseases
            9.3.4.1. Small Molecules
            9.3.4.2. Protein-based Therapeutics
            9.3.4.3. Cell Therapy
            9.3.4.4. Nucleic Acid-based Drugs
        9.3.5. Neurological Diseases
            9.3.5.1. Small Molecules
            9.3.5.2. Protein-based Therapeutics
            9.3.5.3. Cell Therapy
            9.3.5.4. Nucleic Acid-based Drugs
        9.3.6. Others
            9.3.6.1. Small Molecules
            9.3.6.2. Protein-based Therapeutics
            9.3.6.3. Cell Therapy
            9.3.6.4. Nucleic Acid-based Drugs
    9.4. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Workplace, 2017-2031
        9.4.1. Target Identification
        9.4.2. Hit Generation & Lead Identification
        9.4.3. Lead Optimization
        9.4.4. In Vitro Preclinical Studies
        9.4.5. In Vivo Preclinical Studies
        9.4.6. Clinical Studies
    9.5. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Country/Sub-region, 2017-2031
        9.5.1. EU5
        9.5.2. U.K.
        9.5.3. Switzerland
        9.5.4. Rest of Europe
10. China Image-based Cytometry in Cell Analysis Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by End-user, 2017-2031
        10.2.1. Biotechnology & Pharmaceutical Companies
        10.2.2. Academia
        10.2.3. Cosmetic Industry
        10.2.4. Contract Research Organizations
        10.2.5. Contract Development & Manufacturing Organizations
    10.3. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Therapeutic Area, 2017-2031
        10.3.1. Oncology & Immune-oncology
            10.3.1.1. Small Molecules
            10.3.1.2. Protein-based Therapeutics
            10.3.1.3. Cell Therapy
            10.3.1.4. Nucleic Acid-based Drugs
        10.3.2. Cardiovascular & Metabolic Diseases
            10.3.2.1. Small Molecules
            10.3.2.2. Protein-based Therapeutics
            10.3.2.3. Cell Therapy
            10.3.2.4. Nucleic Acid-based Drugs
        10.3.3. Immunology
            10.3.3.1. Small Molecules
            10.3.3.2. Protein-based Therapeutics
            10.3.3.3. Cell Therapy
            10.3.3.4. Nucleic Acid-based Drugs
            10.3.3.5. Nucleic Acid
        10.3.4. Rare Diseases
            10.3.4.1. Small Molecules
            10.3.4.2. Protein-based Therapeutics
            10.3.4.3. Cell Therapy
            10.3.4.4. Nucleic Acid-based Drugs
        10.3.5. Neurological Diseases
            10.3.5.1. Small Molecules
            10.3.5.2. Protein-based Therapeutics
            10.3.5.3. Cell Therapy
            10.3.5.4. Nucleic Acid-based Drugs
        10.3.6. Others
            10.3.6.1. Small Molecules
            10.3.6.2. Protein-based Therapeutics
            10.3.6.3. Cell Therapy
            10.3.6.4. Nucleic Acid-based Drugs
    10.4. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Workplace, 2017-2031
        10.4.1. Target Identification
        10.4.2. Hit Generation & Lead Identification
        10.4.3. Lead Optimization
        10.4.4. In Vitro Preclinical Studies
        10.4.5. In Vivo Preclinical Studies
        10.4.6. Clinical Studies
11. Rest of the World Image-based Cytometry in Cell Analysis Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by End-user, 2017-2031
        11.2.1. Biotechnology & Pharmaceutical Companies
        11.2.2. Academia
        11.2.3. Cosmetic Industry
        11.2.4. Contract Research Organizations
        11.2.5. Contract Development & Manufacturing Organizations
    11.3. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Therapeutic Area, 2017-2031
        11.3.1. Oncology & Immune-oncology
            11.3.1.1. Small Molecules
            11.3.1.2. Protein-based Therapeutics
            11.3.1.3. Cell Therapy
            11.3.1.4. Nucleic Acid-based Drugs
        11.3.2. Cardiovascular & Metabolic Diseases
            11.3.2.1. Small Molecules
            11.3.2.2. Protein-based Therapeutics
            11.3.2.3. Cell Therapy
            11.3.2.4. Nucleic Acid-based Drugs
        11.3.3. Immunology
            11.3.3.1. Small Molecules
            11.3.3.2. Protein-based Therapeutics
            11.3.3.3. Cell Therapy
            11.3.3.4. Nucleic Acid-based Drugs
        11.3.4. Rare Diseases
            11.3.4.1. Small Molecules
            11.3.4.2. Protein-based Therapeutics
            11.3.4.3. Cell Therapy
            11.3.4.4. Nucleic Acid-based Drugs
        11.3.5. Neurological Diseases
            11.3.5.1. Small Molecules
            11.3.5.2. Protein-based Therapeutics
            11.3.5.3. Cell Therapy
            11.3.5.4. Nucleic Acid-based Drugs
        11.3.6. Others
            11.3.6.1. Small Molecules
            11.3.6.2. Protein-based Therapeutics
            11.3.6.3. Cell Therapy
            11.3.6.4. Nucleic Acid-based Drugs
    11.4. Biotechnology & Pharmaceutical Companies Market Value Forecast, by Workplace, 2017-2031
        11.4.1. Target Identification
        11.4.2. Hit Generation & Lead Identification
        11.4.3. Lead Optimization
        11.4.4. In Vitro Preclinical Studies
        11.4.5. In Vivo Preclinical Studies
        11.4.6. Clinical Studies
12. Competition Landscape
    12.1. Market Share Analysis, by Company (2022)
    12.2. Company Profiles
        12.2.1. Nanolive SA
            12.2.1.1. Company Overview
            12.2.1.2. Product Portfolio/Brands with its Description/Features
            12.2.1.3. Strategic Overview/Recent Developments
            12.2.1.4. SWOT Analysis
        12.2.2. PerkinElmer, Inc.
            12.2.2.1. Company Overview
            12.2.2.2. Product Portfolio/Brands with its Description/Features
            12.2.2.3. Financial Overview
            12.2.2.4. Strategic Overview/Recent Developments
            12.2.2.5. SWOT Analysis
        12.2.3. Sartorius AG
            12.2.3.1. Company Overview
            12.2.3.2. Product Portfolio/Brands with its Description/Features
            12.2.3.3. Financial Overview
            12.2.3.4. Strategic Overview/Recent Developments
            12.2.3.5. SWOT Analysis
        12.2.4. Thermo Fisher Scientific Inc.
            12.2.4.1. Company Overview
            12.2.4.2. Product Portfolio/Brands with its Description/Features
            12.2.4.3. Financial Overview
            12.2.4.4. Strategic Overview/Recent Developments
            12.2.4.5. SWOT Analysis
        12.2.5. Merck KGaA
            12.2.5.1. Company Overview
            12.2.5.2. Product Portfolio/Brands with its Description/Features
            12.2.5.3. Financial Overview
            12.2.5.4. Strategic Overview/Recent Developments
            12.2.5.5. SWOT Analysis
        12.2.6. Charles River Laboratories
            12.2.6.1. Company Overview
            12.2.6.2. Product Portfolio/Brands with its Description/Features
            12.2.6.3. Financial Overview
            12.2.6.4. SWOT Analysis
        12.2.7. Yokogawa Electric Corporation
            12.2.7.1. Company Overview
            12.2.7.2. Product Portfolio/Brands with its Description/Features
            12.2.7.3. Financial Overview
            12.2.7.4. SWOT Analysis
        12.2.8. Carl Zeiss AG
            12.2.8.1. Company Overview
            12.2.8.2. Product Portfolio/Brands with its Description/Features
            12.2.8.3. Financial Overview
            12.2.8.4. Strategic Overview/Recent Developments
            12.2.8.5. SWOT Analysis

List of Tables

Table 01: Global Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 02: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031

Table 03: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Oncology & Immune-oncology, 2017-2031

Table 04: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Cardiovascular & Metabolic Diseases, 2017-2031

Table 05: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Immunology, 2017-2031

Table 06: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Rare Diseases, 2017-2031

Table 07: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Neurological Diseases, 2017-2031

Table 08: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Others, 2017-2031

Table 09: Global Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Workplace, 2017-2031

Table 10: Global Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 11: U.S. Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 12: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031

Table 13: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Oncology & Immune-oncology, 2017-2031

Table 14: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Cardiovascular & Metabolic Diseases, 2017-2031

Table 15: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Immunology, 2017-2031

Table 16: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Rare Diseases, 2017-2031

Table 17: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Neurological Diseases, 2017-2031

Table 18: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Others, 2017-2031

Table 19: U.S. Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Workplace, 2017-2031

Table 20: Europe Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 21: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031

Table 22: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Oncology & Immune-oncology, 2017-2031

Table 23: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Cardiovascular & Metabolic Diseases, 2017-2031

Table 24: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Immunology, 2017-2031

Table 25: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Rare Diseases, 2017-2031

Table 26: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Neurological Diseases, 2017-2031

Table 27: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Others, 2017-2031

Table 28: Europe Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Workplace, 2017-2031

Table 29: Europe Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 30: China Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 31: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031

Table 32: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Oncology & Immune-oncology, 2017-2031

Table 33: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Cardiovascular & Metabolic Diseases, 2017-2031

Table 34: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Immunology, 2017-2031

Table 35: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Rare Diseases, 2017-2031

Table 36: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Neurological Diseases, 2017-2031

Table 37: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Others, 2017-2031

Table 38: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Workplace, 2017-2031

Table 39: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 40: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Therapeutic Area, 2017-2031

Table 41: China Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Oncology & Immune-oncology, 2017-2031

Table 42: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Cardiovascular & Metabolic Diseases, 2017-2031

Table 43: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Immunology, 2017-2031

Table 44: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Rare Diseases, 2017-2031

Table 45: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Neurological Diseases, 2017-2031

Table 46: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Others, 2017-2031

Table 47: Rest of the World Biotechnology & Pharmaceutical Companies Image-based Cytometry in Cell Analysis Market Value (US$ Mn) Forecast, by Workplace, 2017-2031

世界の産業調査レポート販売サイトを運営しているマーケットリサーチセンターです。
• 英文レポート名：Image Based Cytometry in Cell Analysis Market (End-user: Biotechnology & Pharmaceutical Companies, Academia, Cosmetic Industry, Contract Research Organizations, and Contract Development & Manufacturing Organizations) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
• 日本語訳：細胞分析用イメージベースサイトメトリーの世界市場（2023年-2031年）：バイオテクノロジー・製薬会社、学術、化粧品産業、受託研究機関、受託開発・製造機関
• レポートコード：MRC2312A035 ▷ お問い合わせ（見積依頼・ご注文・質問）